Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-12-20
1994-06-14
Nutter, Nathan M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514385, 514386, 514396, 514553, 514501, 514563, 514564, 514579, 514631, 514636, 514646, A01N 4354, A01N 4350, A61K 31415, A61K 31505
Patent
active
053210301
ABSTRACT:
The present invention relates to the use of analogs of creatine, such as cyclocreatine, as antiviral agents. Analogs of creatine can be used as antiviral agents against a variety of viruses, particularly DNA viruses, such as Herpes viruses (e.g., HSV-1, HSV-2, cytomegaloviruses, Varicella-Zoster virus) and adenovirus. The invention further relates to creatine analogs including four classes of creatine analogs selected as candidate antiviral compounds: (1) creatine analogs that can be phosphorylated by creatine kinase but differ in their phosphoryl group transfer potential, (2) bisubstrate inhibitors of creatine kinase comprising covalently linked structural analogs of adenosine triphosphate (ATP) and creatine, (3) creatine analogs which can act as irreversible inhibitors of creatine kinase, and (4) N-phosphorocreatine analogs bearing non-transferable moieties which mimic the N-phosphoryl group.
REFERENCES:
patent: 4128655 (1978-12-01), Hunsucker et al.
van der Krol et al. Biotechniques 6(10):958-976, 1988.
R. F. Dietrich and G. L. Kenyon, "Synthesis and Investigation with Creatine Kinases of trans-2-Imino-1,3-diazabicyclo[3.3.0]octane-8-carboxylic Acid, a Bicyclic Analog of Creatine".
Bioorganic Chemistry, vol. 12, No. 3, Sep. 1984, pp. 221-228.
R. F. Dietrich et al., "Carbon-13 Nuclear Magnetic Resonance Studies of Creatine, Creatinine and Some Their Analogs", Organic Magnetic Resonance, vol. 13, No. 2, Feb. 1980, pp. 79-88.
Yoshio Sakagami and Senzo Kagi, "Studies on the In Vitro Synergistic Action of Surface Active Imidazoline Deriatives with Tetracycline Group", The Journal of Antibiotics, Ser. A, vol. 19, No. 4, pp. 161-165.
J. J. Roberts and J. B. Walker, "Synthesis and Accumulation of an Extremely Stable High-Energy Phosphate Compound by Muscle, Heart, and Brain of Animals Fed the Creatine Analog, 1-Carboxyethyl-2-Iminoimidazolidine (Homocyclocreatine)", Archives of Biochemistry and Biophysics, vol. 220, No. 2, Feb. 1, 1983, pp. 563-571.
T. Wang, "Synthesis and Properties of N-Acetimidoyl Derivative of Glycine and Sarcosine", J. Org. Chem., vol. 39, No. 24, 1974, pp. 3591-3594.
El Hiyani, L. et al., Biological Abstracts, 84(9): AB-729, No. 89661 (1987) and Chem. -Biol. Interactions, 62:167-178 (1987).
Toleikis, A. T. et al., Biological Abstracts, 86(11):AB-170, No. 110912 (1988) and Biokhimiya, 53(4): 649-654 (1988).
Moss, R. J. et al., J. Med. Chem. 31: 786-790 (1988).
Kappler, F. et al., J. Med. Chem., 25: 1179-1184 (1982).
Miranda, A. F. et al., Proc. Natl. Acad. Sci. USA, 80:6581-6585 (1983).
Rubery, E. D. et al., Biological Abstracts, 76(5): 3844, No. 35410 (1983) and Eur. J. Cancer Clin. Oncol., 18(10): 951-956 (1982).
Gazdar, A. F. et al., Biological Abstracts, 805:AB-578, No. 41779 (1985) and Cancer Res., 45(6):2924-2930 (1985).
Maker, H. S. et al., Biological Abstracts, 78(2): 1470, No. 12908 (1984) and Res. Comm. Chem. Pathol. Pharmacol., 40(3):355-366 (1983).
Daouk, G. H. et al., J. Biol. Chem., 263(5): 2442-2446 (Feb. 15, 1988).
Lillie, J. W. et al., Cell, 50:1091-1100 (1987).
Inhorn, L. et al., Biological Abstracts, 82(2): AB-700, No. 17059 (1988) and Blood, 71(4):1003-1011 (1988).
Rivedal, E. and T. Sanner, Chemical Abstracts, 103(9): 50, No. 153568m (1985) and Cancer Lett., 28(1): 9-17 (1985).
Folbergrova, J. et al., Biological Abstracts, 84(2): AB-684, No. 17158 (1987) and Neoplasma, 34(1): 3-14 (1987).
Mariman, E. C. M. et al., Genomics, 1: 126-137 (1987).
Mariman, E. C. M. et al., Nucl. Acids Res., 17:6385 (1989).
Zerler, B. et al., Mol. Cell. Biol., 7:821-829 (1987).
Shields, R. P. et al., Lab. Inest., 33:151-158 (1975).
McLaughlin, A. C. et al., J. Biol. Chem., 247:4382-4388 (1972).
Kaddurah-Daouk, R. et al., Mol. Cell Biol. 10(4): 1476-1483 (1990).
Annesley, T. M. and J. B. Walker, J. Biol. Chem., 253: 8120-8125 (1978).
Whyte, P. et al., Nature, 334:124-129 (Jul. 1988).
Ch'ng, J. L. C. et al., Proc. Natl. Acad. Sci. U.S.A., 86:10006-10010 (Dec., 1989).
Colberg-Poley, A. M. and Santomenna, L. D., Virology, 166(1):217-228 (1988).
Rowley, G. L. et al., J. Am. Chem. Soc., 93(21):5542-5551 (1971).
Lowe, G. and B. S. Sproat, J. Biol. Chem., 255(9):3944-3951 (1980).
Roberts, J. J. and J. B. Walker, J. Biol. Chem., 260(25):13502-13508 (1985).
Burbaum Jonathan J.
Forsyth Craig J.
Kaddurah-Daouk Rima
Lillie James W.
Widlanski Theodore S.
Amira, Inc.
Nutter Nathan M.
LandOfFree
Creatine analogs having antiviral activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Creatine analogs having antiviral activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Creatine analogs having antiviral activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1249441